Open access
Jul 2026
Rapid and robust immune response boosting with potent, next-generation adjuvant in viral vector-primed primates
A modified HIV-1 vaccine regimen incorporating next-generation adjuvants to improve immune responses and vaccine efficacy in a gold standard, pre-clinical primate model indicated that novel adjuvants represent a promising strategy for improving immune responses to protein immunogens.
Hannah A. D. King, C. Subra, Emily Tourtellott et al.
· Journal of Virology · 0 citations